BioDevas Laboratoires Patent for Aromatic Plant Extract Flea Treatment Composition
Summary
BioDevas Laboratoires has been granted USPTO Application US20260108576A1 for a composition against ectoparasites, specifically fleas affecting domestic mammals. The composition comprises a mixture of extracts from aromatic plants, including lemon balm, thyme, rosemary, wormwood, and lemongrass. The application was filed on December 22, 2025, under Application No. 19428445, with inventors François BLUA and Jean Louis BLUA. The patent covers veterinary and pharmaceutical compositions incorporating the extract mixture, along with animal food products containing the composition and methods for preparing and administering the composition for flea prevention or treatment.
“A composition including a mixture of extracts of aromatic plants, and in particular extracts of lemon balm, thyme, rosemary, wormwood and lemongrass, veterinary or pharmaceutical compositions including the composition and a food for non-human animals including the composition.”
About this source
USPTO classification A61K covers pharmaceutical preparations: formulations, dosage forms, combination therapies, delivery systems, and the vehicles that carry active ingredients. Every newly published application in A61K lands in this feed, around 245 a month. Applications publish 18 months after filing, so this feed reveals what pharma formulators at major sponsors and generics were working on in the prior year and a half. Watch this if you compete in drug formulation, file freedom-to-operate analyses, scout competitive drug products before clinical readouts, or follow novel delivery platforms like nanoparticles, lipid carriers, and long-acting injectables.
What changed
The USPTO published Application US20260108576A1, granting BioDevas Laboratoires exclusive rights to a flea treatment composition derived from a blend of five aromatic plant extracts: lemon balm, thyme, rosemary, wormwood, and lemongrass. The composition is intended for veterinary and pharmaceutical use on domestic mammals, and may also be incorporated into animal food products.
Manufacturers of veterinary pharmaceuticals, pet flea treatments, and animal feed additives should be aware of this newly granted intellectual property position. Competing products that rely on similar aromatic plant extract formulations may require licensing or design-around strategies to avoid infringement on the granted claims. The patent scope extends to both the preparation method and the administration method for flea prevention and treatment in non-human animals.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOSITION AGAINST ECTOPARASITES
Application US20260108576A1 Kind: A1 Apr 23, 2026
Assignee
BIODEVAS LABORATOIRES
Inventors
François BLUA, Jean Louis BLUA
Abstract
A composition including a mixture of extracts of aromatic plants, and in particular extracts of lemon balm, thyme, rosemary, wormwood and lemongrass, veterinary or pharmaceutical compositions including the composition and a food for non-human animals including the composition. Also, a method for preparing the composition and a method for the prevention or treatment of flea infestation that include the administration of the composition to a domestic mammal.
CPC Classifications
A61K 36/53 A23K 10/30 A23K 50/42 A61K 36/282 A61K 36/48 A61K 36/899 A61P 33/14
Filing Date
2025-12-22
Application No.
19428445
Mentioned entities
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.